Literature DB >> 26901811

In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection.

Xiaonan Zhang, Wei Lu, Ye Zheng, Weixia Wang, Lu Bai, Liang Chen, Yanling Feng, Zhanqing Zhang, Zhenghong Yuan.   

Abstract

Persistent hepatitis B virus (HBV) infection is established by the formation of an intranuclear pool of covalently closed circular DNA (cccDNA) in the liver. Very little is known about the intrahepatic distribution of HBV cccDNA in infected patients, particularly at the single-cell level. Here, we established a highly sensitive and specific ISH assay for the detection of HBV RNA, DNA, and cccDNA. The specificity of our cccDNA probe set was confirmed by its strict intranuclear signal and by a series of Southern blot analyses. Use of our in situ assay in conjunction with IHC or immunofluorescence uncovered a surprisingly mosaic distribution of viral antigens and nucleic acids. Most strikingly, a mutually exclusive pattern was found between HBV surface antigen-positive (HBsA-positive) and HBV DNA- and cccDNA-positive cells. A longitudinal observation of patients over a 1-year period of adeforvir therapy confirmed the persistence of a nuclear reservoir of viral DNA, although cytoplasmic DNA was effectively depleted in these individuals. In conclusion, our method for detecting viral nucleic acids, including cccDNA, with single-cell resolution provides a means for monitoring intrahepatic virological events in chronic HBV infection. More important, our observations unravel the complexity of the HBV life cycle in vivo.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26901811      PMCID: PMC4767362          DOI: 10.1172/JCI83339

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy.

Authors:  L Luckenbaugh; K M Kitrinos; W E Delaney; J Hu
Journal:  J Viral Hepat       Date:  2014-11-14       Impact factor: 3.728

2.  Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol.

Authors:  S R Florell; C M Coffin; J A Holden; J W Zimmermann; J W Gerwels; B K Summers; D A Jones; S A Leachman
Journal:  Mod Pathol       Date:  2001-02       Impact factor: 7.842

3.  Single-copy gene detection using branched DNA (bDNA) in situ hybridization.

Authors:  A N Player; L P Shen; D Kenny; V P Antao; J A Kolberg
Journal:  J Histochem Cytochem       Date:  2001-05       Impact factor: 2.479

4.  A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures.

Authors:  Dawei Cai; Hui Nie; Ran Yan; Ju-Tao Guo; Timothy M Block; Haitao Guo
Journal:  Methods Mol Biol       Date:  2013

Review 5.  Validating transcripts with probes and imaging technology.

Authors:  Shalev Itzkovitz; Alexander van Oudenaarden
Journal:  Nat Methods       Date:  2011-03-30       Impact factor: 28.547

6.  Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus.

Authors:  Thomas B Lentz; Daniel D Loeb
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

7.  Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA.

Authors:  M Dandri; M R Burda; H Will; J Petersen
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

8.  Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection.

Authors:  T Tu; W S Mason; A D Clouston; N A Shackel; G W McCaughan; M M Yeh; E R Schiff; A R Ruszkiewicz; J W Chen; H A J Harley; U H Stroeher; A R Jilbert
Journal:  J Viral Hepat       Date:  2015-01-26       Impact factor: 3.728

9.  Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.

Authors:  Danny Ka-Ho Wong; Wai-Kay Seto; James Fung; Philip Ip; Fung-Yu Huang; Ching-Lung Lai; Man-Fung Yuen
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-01       Impact factor: 11.382

10.  A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR.

Authors:  Yanwei Zhong; Shuangye Hu; Chen Xu; Yulai Zhao; Dongping Xu; Yanqing Zhao; Jingmin Zhao; Zhibin Li; Xiuchang Zhang; Hongfei Zhang; Jin Li
Journal:  BMC Infect Dis       Date:  2014-12-03       Impact factor: 3.090

View more
  36 in total

1.  New perspectives on the hepatitis B virus life cycle in the human liver.

Authors:  Peter A Revill; Stephen A Locarnini
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

2.  HBsAg loss in chronic hepatitis B: pointers to the benefits of curative therapy.

Authors:  Geoffrey Dusheiko; Bo Wang; Ivana Carey
Journal:  Hepatol Int       Date:  2016-05-31       Impact factor: 6.047

3.  Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.

Authors:  Natalia Freitas; Tetyana Lukash; Sumedha Gunewardena; Benjamin Chappell; Betty L Slagle; Severin O Gudima
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

4.  A global scientific strategy to cure hepatitis B.

Authors:  Peter A Revill; Francis V Chisari; Joan M Block; Maura Dandri; Adam J Gehring; Haitao Guo; Jianming Hu; Anna Kramvis; Pietro Lampertico; Harry L A Janssen; Massimo Levrero; Wenhui Li; T Jake Liang; Seng-Gee Lim; Fengmin Lu; M Capucine Penicaud; John E Tavis; Robert Thimme; Fabien Zoulim
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-10

Review 5.  A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook.

Authors:  Anna Kramvis; Kyong-Mi Chang; Maura Dandri; Patrizia Farci; Dieter Glebe; Jianming Hu; Harry L A Janssen; Daryl T Y Lau; Capucine Penicaud; Teresa Pollicino; Barbara Testoni; Florian Van Bömmel; Ourania Andrisani; Maria Beumont-Mauviel; Timothy M Block; Henry L Y Chan; Gavin A Cloherty; William E Delaney; Anna Maria Geretti; Adam Gehring; Kathy Jackson; Oliver Lenz; Mala K Maini; Veronica Miller; Ulrike Protzer; Jenny C Yang; Man-Fung Yuen; Fabien Zoulim; Peter A Revill
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-20       Impact factor: 73.082

6.  Single Hepatocyte Hepatitis B Virus Transcriptional Landscape in HIV Coinfection.

Authors:  Ashwin Balagopal; Hyon S Hwang; Tanner Grudda; Jeffrey Quinn; Richard K Sterling; Mark S Sulkowski; Chloe L Thio
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

Review 7.  HBV in 2016: Global and immunotherapeutic insights into hepatitis B.

Authors:  Mala K Maini; Antonio Bertoletti
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

Review 8.  Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.

Authors:  Andrew Vaillant
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

9.  Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter.

Authors:  Peter A C Wing; Peter Jianrui Liu; James M Harris; Andrea Magri; Thomas Michler; Xiaodong Zhuang; Helene Borrmann; Rosalba Minisini; Nicholas R Frampton; Jochen M Wettengel; Laurent Mailly; Valentina D'Arienzo; Tobias Riedl; Luis Nobre; Michael P Weekes; Mario Pirisi; Mathias Heikenwalder; Thomas F Baumert; Ester M Hammond; David R Mole; Ulrike Protzer; Peter Balfe; Jane A McKeating
Journal:  J Hepatol       Date:  2021-01-29       Impact factor: 30.083

10.  Establishment of a fluorescent in situ hybridization assay for imaging hepatitis B virus nucleic acids in cell culture models.

Authors:  Xiaonan Zhang; Lei Yue; Zhanqing Zhang; Zhenghong Yuan
Journal:  Emerg Microbes Infect       Date:  2017-11-08       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.